Trial · NCT04954313
Outcomes16
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 16 of 16
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Impact of Treatment on Change in Oral Health Measures | Comparing T1 (day 90) and T4 (day 360) | Data include imputation. Predictions based on linear mixed models were used for imputation. | millimeters (probing depth difference) | LEAST_SQUARES_MEAN |
| PRIMARY | Association Between Changes in Oral Health (Probing Depth) and Changes in Systemic Health (HbA1c) | Comparing T0 (day 0) and T4 (day 360) | Analysis population includes only participants meeting the following criteria: (1) HbA1c data was available at T0 and T4 time points, (2) probing depth data was available at T0 and T4 time points, and (3) screening HbA1c \>= 5.7 (if screening value was not available, T0 value of HbA1c \>= 5.7 was used as proxy). | Pearson correlation coefficient | NUMBER |
| PRIMARY | Association Between Changes in Oral Health and Changes in Systemic Health (Flow-mediated Dilation) | Comparing T0 (day 0) and T4 (day 360) | Analysis population includes only participants meeting the following criteria: (1) flow mediated dilation data was available at T0 and T4 time points, (2) probing depth data was available at T0 and T4 time points. | Pearson correlation coefficient | NUMBER |
| SECONDARY | Change in Emotional Wellbeing | Comparing T0 (day 0) and T4 (day 360) | Analysis population includes only participants who completed the survey at T0 and T4 time points. | scores on a scale | MEAN |
| SECONDARY | Change in Beliefs About Periodontal Disease | Comparing T0 (day 0) and T4 (day 360) | Analysis population includes only participants who completed the survey at T0 and T4 time points. | scores on a scale | MEAN |
| SECONDARY | Change in Bleeding on Probing | Comparing T0 (day 0) and T4 (day 360) | Analysis population includes only participants who received dental assessment at T0 and T4 time points. | scores on a scale | MEAN |
| SECONDARY | Change in Gingival Index | Comparing T0 (day 0) and T4 (day 360) | Analysis population includes only participants who received dental assessment at T0 and T4 time points. | scores on a scale | MEAN |
| SECONDARY | Percent Change in Clinical Attachment Level (CAL) | Comparing T0 (day 0) and T4 (day 360) | Analysis population includes only participants who received dental assessment at T0 and T4 time points. | % change | MEAN |
| SECONDARY | Change in Dental Plaque Index | Comparing T0 (day 0) and T4 (day 360) | Analysis population includes only participants who received dental assessment at T0 and T4 time points. | scores on a scale | MEAN |
| SECONDARY | Change in Flow-mediated Dilation | Comparing T0 (day 0) and T4 (day 360) | Some participants did not have FMD measured at T0 and/or T4 and are not included in the T4-T0 comparison. Missing data arises from a combination of participant withdrawal/loss to followup and poor ultrasound data quality. | % change | MEAN |
| SECONDARY | Percent Change in Glycated Hemoglobin (HbA1c) (Prediabetic and Type 2 Diabetic Cohorts) | Comparing T0 (day 0) and T4 (day 360) | Analysis population includes only participants meeting the following criteria: (1) biomarker data was available at T0 and T4 time points and (2) screening HbA1c \>= 5.7 (if screening value was not available, T0 value of HbA1c \>= 5.7 was used as proxy). | % change | MEAN |
| SECONDARY | Percent Change in Carotid Intima Media Thickness (IMT) | Comparing T0 (day 0) and T4 (day 360) | Some participants are missing measurement data at either T0 or T4 timepoints, precluding calculation of T0 to T4 percent change. Missing data arises from a combination of participant withdrawal/loss to followup and poor ultrasound data quality. | % change | MEAN |
| SECONDARY | Percent Change of High Sensitivity C-reactive Protein (Hs-CRP) | Comparing T0 (day 0) and T4 (day 360) | Analysis population includes only participants for whom biomarker data was available at T0 and T4 time points. | % change | MEAN |
| SECONDARY | Percent Change in Total Cholesterol | Comparing T0 (day 0) and T4 (day 360) | Analysis population includes only participants for whom biomarker data was available at T0 and T4 time points. | % change | MEAN |
| SECONDARY | Percent Change in Low Density Lipoprotein (LDL) Cholesterol | Comparing T0 (day 0) and T4 (day 360) | Analysis population includes only participants for whom biomarker data was available at T0 and T4 time points. | % change | MEAN |
| SECONDARY | Percent Change in Triglycerides | Comparing T0 (day 0) and T4 (day 360) | Analysis population includes only participants for whom biomarker data was available at T0 and T4 time points. | % change | MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04954313/outcomes